Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,293 | N/A | 3 | 60 | N/A |
| Other current assets | 5 | 0 | 0 | 0 | 0 |
| TOTAL | $1,301 | $N/A | $3 | $60 | $N/A |
| Non-Current Assets | |||||
| Intangibles | 160 | 1 | 0 | 4 | 0 |
| TOTAL | $160 | $1 | $N/A | $4 | $N/A |
| Total Assets | $1,461 | $1 | $6 | $64 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30 | 0 | 0 | 4 | 0 |
| Other current liabilities | 793 | 23 | 3 | 1 | N/A |
| TOTAL | $823 | $23 | $3 | $5 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $823 | $23 | $3 | $5 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 707 | 719 | 51 | N/A | N/A |
| Common Shares | 3 | N/A | 5 | 5 | N/A |
| Retained earnings | -1,683 | N/A | -59 | -2 | N/A |
| TOTAL | $638 | $N/A | $2 | $59 | $N/A |
| Total Liabilities And Equity | $1,461 | $23 | $6 | $64 | $0 |